Physician profile
Marilee Olson
NPI 1326304536
$571.31
in general payments reported to CMS, 2019-2025
11 companies · $77.73 in 2025
The $77.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.63 · 2022: $129 · 2023: $143 · 2024: $125 · 2025: $77.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $142.47 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.18 | 2024-2025 | Relistor |
| Si-Bone, INC. | $77.39 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $60.45 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $45.73 | 2023 | Seglentis |
| Valinor Pharma, LLC | $35.37 | 2024 | Movantik |
| Protega Pharmaceutials INC | $28.01 | 2023 | Roxybond |
| Boston Scientific Corporation | $15.12 | 2025 | Intracept |
| Averitas Pharma INC. | $13.36 | 2023 | Qutenza |
| Lilly USA, LLC | $12.94 | 2021 | |
| Uswm, LLC | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilee Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.